Literature DB >> 18221805

Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study.

Julie Turmel1, Frédéric Sériès, Louis-Philippe Boulet, Paul Poirier, Jean-Claude Tardif, Josep Rodés-Cabeau, Eric Larose, Olivier F Bertrand.   

Abstract

BACKGROUND: Sleep apnea hypopnea syndrome (SAHS) is a predictive factor of cardiovascular disease. We hypothesized that SAHS could influence coronary atherosclerosis plaque volume as assessed by 3-dimensional intravascular ultrasound (3D-IVUS).
METHODS: Participating patients were identified from 2 studies assessing the progression of atherosclerosis in stable coronary artery disease using coronary 3D-IVUS.
RESULTS: Nineteen patients, aged 61+/-8 years, with a body mass index of 29+/-5 kg/m(2) were studied. Increased apnea-hypopnea index (AHI) >or=15 was found in 12/19 patients (63%). Patients with AHI>or=15 had larger coronary atherosclerotic plaque volume than patients with AHI<15 (238+/-69 mm(3) vs 169+/-64 mm(3), p=0.047) and the difference was even larger in patients with obstructive apnea/hypopnea episodes compared to patients without (243+/-70 mm(3) vs 170+/-59 mm(3), p=0.03). There was a significant positive correlation between obstructive AHI and coronary atherosclerotic plaque volume (r=0.6, p=0.01). A significant positive correlation was also demonstrated between respiratory arousal index and coronary atherosclerotic plaque volume (r=0.6, p=0.02) and between total arousal index and coronary atherosclerotic plaque volume (r=0.5, p=0.03).
CONCLUSION: In patients with stable coronary artery disease, there was a significant relationship between the frequency of obstructive sleep apnea/hypopnea episodes and sleep fragmentation and the importance of coronary atherosclerotic plaque volume. 3D-IVUS is well suited to correlate coronary atherosclerosis and sleep breathing disorders at early stages.

Entities:  

Mesh:

Year:  2008        PMID: 18221805     DOI: 10.1016/j.ijcard.2007.11.063

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  18 in total

1.  Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic.

Authors:  Navneet Sharma; Justin Lee; Irini Youssef; Moro O Salifu; Samy I McFarlane
Journal:  J Sleep Disord Ther       Date:  2017-03-10

Review 2.  Obstructive sleep apnea: an emerging risk factor for atherosclerosis.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  Chest       Date:  2011-08       Impact factor: 9.410

3.  Obstructive sleep apnea increases the risk of cardiac events after percutaneous coronary intervention: a meta-analysis of prospective cohort studies.

Authors:  Hua Qu; Ming Guo; Ying Zhang; Da-Zhuo Shi
Journal:  Sleep Breath       Date:  2017-04-18       Impact factor: 2.816

Review 4.  Obstructive Sleep Apnoea and Type 2 Diabetes.

Authors:  Abd A Tahrani; Asad Ali
Journal:  Eur Endocrinol       Date:  2014-02-28

Review 5.  Obstructive sleep apnoea and coronary artery disease.

Authors:  Swapna Mandal; Brian D Kent
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 6.  Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.

Authors:  Claire Arnaud; Maurice Dematteis; Jean-Louis Pepin; Jean-Philippe Baguet; Patrick Lévy
Journal:  Semin Immunopathol       Date:  2009-04-29       Impact factor: 9.623

7.  Attenuated macrophage cholesterol efflux function in patients with obstructive sleep apnea-hypopnea syndrome.

Authors:  Rui-Yi Xu; Rong Huang; Yi Xiao; Lian-Feng Chen; Xue Lin; Quan Fang; Xiao-Wei Yan
Journal:  Sleep Breath       Date:  2014-07-08       Impact factor: 2.816

8.  Influence of sleep-disordered breathing assessed by pulse oximetry on long-term clinical outcomes in patients who underwent percutaneous coronary intervention.

Authors:  Shoichiro Yatsu; Ryo Naito; Takatoshi Kasai; Hiroki Matsumoto; Jun Shitara; Megumi Shimizu; Azusa Murata; Takao Kato; Shoko Suda; Masaru Hiki; Eiryu Sai; Katsumi Miyauchi; Hiroyuki Daida
Journal:  Clin Res Cardiol       Date:  2018-03-31       Impact factor: 5.460

Review 9.  Obstructive Sleep Apnoea and Vascular Disease in Patients with Type 2 Diabetes.

Authors:  Abd A Tahrani
Journal:  Eur Endocrinol       Date:  2015-08-19

Review 10.  Recent Advances in Studies on the Role of Neuroendocrine Disorders in Obstructive Sleep Apnea-Hypopnea Syndrome-Related Atherosclerosis.

Authors:  Wanda Wang; Yanli Zheng; Meimei Li; Shu Lin; Huili Lin
Journal:  Nat Sci Sleep       Date:  2021-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.